Neural Stem Cell Discovery Has Treatment Potential
the Neurology Advisor take:
Transforming growth factor-beta may act as a switch-signal in the temporal patterning of the brain that executes the transition between early and late phases of neurogenesis, researchers have discovered.
The findings may provide a framework to modulate temporal identity and potency of neural cells in stem-cell engineering, which could lead to novel treatments for psychiatric and neurodegenerative diseases, according to Johan Ericson, PhD, of the Karolinska Institute in Stockholm, Sweden, and colleague.
Transforming growth factor-beta (TGF-beta) signaling executes the motor neuron (MN) to serotonergic neuron (5HTN) temporal fate switch in ventral hindbrain progenitors, the study findings showed. TGF-beta also suppressed early-born neuron and induced late-born cell types in different regions of the central nervous system.
Additionally, young Nkx2.2+ hindbrain progenitors can produce late-born 5HTN and that the timing of TGF-beta2 activation and execution of MN to 5HTN switch is intrinsically programmed within the Nkx2.2+ temporal lineage downstream of Sonic hedgehog (Shh), the researchers found.
This data suggests a novel “hierarchical dominance” model of sequential fate specification, where transcription factors promoting MN- and 5HTN-fate co-exist in young progenitors but where the activity of Phox2b predominates over 5HTN-fate determinants at early developmental stages.
Noting the important roles that 5HTNs play in psychiatric and neurodegenerative diseases, the results of this study suggest that extrinsic cues that regulate temporal neurogenesis can be used to bypass early phases, thus allowing stem cells to facilitate production of late-born and clinically relevant neurons.
Neural Stem Cell Insights Offer New Treatment Avenues
New insights into how molecular time signaling controls stem cells at different stages of brain development could have implications for the development of novel treatments for psychiatric and neurodegenerative diseases, researchers reported.
Researchers from Karolinska Institute, in Stockholm, Sweden, discovered that TGF-beta acts as a switch-signal in temporal patterning of the vertebrate brain that executes the transition between early and late phases of neurogenesis.
The identification of TGF-beta as a temporal switch signal and regulator of neural progenitor potential provides a future framework to modulate temporal identity and potency of neural cells in stem-cell engineering.
Next Article in General Neurology
Neurology Advisor Articles
- Oral Film Formulation of Clobazam Gets FDA Approval for LGS
- Lasmiditan NDA Submitted for Acute Treatment of Migraine
- Nusinersen May Be Effective for Short-Term Motor Function Improvements in Spinal Muscular Atrophy
- High Daily Stress Linked to Migraine Prevalence in Women
- New Blood Test Identifies Metabolic Subtypes Linked to Autism Spectrum Disorder
- New Diagnostic Criteria for Neurosarcoidosis: What You Need to Know
- Guideline for Diagnosis and Treatment of Idiopathic Intracranial Hypertension
- Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine
- Ivy League Rule Change Linked to Fewer Concussions During NCAA Football Games
- Biomarkers of Alzheimer Disease Observed in Down Syndrome
- Cardiovascular Autonomic Neuropathy Raises Fall Risk in Parkinson Disease
- No Efficacy Signal for Fluoxetine in EV-D68 Acute Flaccid Myelitis
- One-Third of Peds Medication Errors Due to Usability Issues
- Ocrevus Labeling Updated With New Info on Timing of Vaccine Administration
- Approaches for Better Diagnosis of Pediatric Multiple Sclerosis